| Modulating glycolysis to improve cancer therapy C Chelakkot, VS Chelakkot, Y Shin, K Song International Journal of Molecular Sciences 24 (3), 2606, 2023 | 157 | 2023 |
| CD24 overexpression is associated with poor prognosis in luminal A and triple-negative breast cancer MJ Kwon, J Han, JH Seo, K Song, HM Jeong, JS Choi, YJ Kim, SH Lee, ... PloS one 10 (10), e0139112, 2015 | 107 | 2015 |
| Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival YL Choi, E Oh, S Park, Y Kim, YH Park, K Song, EY Cho, YC Hong, ... BMC cancer 10, 1-15, 2010 | 86 | 2010 |
| Molecular changes in solitary fibrous tumor progression HK Park, DB Yu, M Sung, E Oh, M Kim, JY Song, MS Lee, K Jung, ... Journal of Molecular Medicine 97, 1413-1425, 2019 | 73 | 2019 |
| Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer MJ Kwon, RN Kim, K Song, S Jeon, HM Jeong, JS Kim, J Han, S Hong, ... Oncotarget 8 (54), 92209, 2017 | 40 | 2017 |
| Glycoengineering of interferon-β 1a improves its biophysical and pharmacokinetic properties K Song, IS Yoon, NA Kim, DH Kim, J Lee, HJ Lee, S Lee, S Choi, MK Choi, ... PloS one 9 (5), e96967, 2014 | 37 | 2014 |
| UBE2C overexpression aggravates patient outcome by promoting estrogen-dependent/independent cell proliferation in early hormone receptor-positive and HER2-negative breast cancer YJ Kim, G Lee, J Han, K Song, JS Choi, YL Choi, YK Shin Frontiers in Oncology 9, 1574, 2020 | 33 | 2020 |
| Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology YJ Kim, M Kim, HK Park, DB Yu, K Jung, K Song, YL Choi Laboratory Investigation 99 (9), 1309-1320, 2019 | 23 | 2019 |
| TM4SF4 and LRRK2 are potential therapeutic targets in lung and breast cancers through outlier analysis K Jung, JS Choi, BM Koo, YJ Kim, JY Song, M Sung, ES Chang, KW Noh, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2021 | 17 | 2021 |
| An immune–magnetophoretic device for the selective and precise enrichment of circulating tumor cells from whole blood C Chelakkot, J Ryu, MY Kim, JS Kim, D Kim, J Hwang, SH Park, SB Ko, ... Micromachines 11 (6), 560, 2020 | 12 | 2020 |
| Development of human monoclonal antibody for Claudin-3 overexpressing carcinoma targeting H Yang, H Park, YJ Lee, JY Choi, TE Kim, N Rajasekaran, S Lee, K Song, ... Biomolecules 10 (1), 51, 2019 | 12 | 2019 |
| Nuclear respiratory Factor-1, a novel SMAD4 binding protein, represses TGF-β/SMAD4 signaling by functioning as a transcriptional cofactor N Rajasekaran, K Song, JH Lee, Y Wei, ÖC Erkin, H Lee, YK Shin International Journal of Molecular Sciences 22 (11), 5595, 2021 | 11 | 2021 |
| Comparison of genesWell BCT score with Oncotype DX recurrence score for risk classification in asian women with hormone receptor-positive, HER2-negative early breast cancer MJ Kwon, JE Lee, J Jeong, SU Woo, J Han, B Kang, JE Kim, Y Moon, ... Frontiers in Oncology 9, 667, 2019 | 11 | 2019 |
| Antibody-based targeting of interferon-beta-1a mutein in HER2-positive cancer enhances antitumor effects through immune responses and direct cell killing CG Lee, TE Kim, S Hong, J Chu, JE Kang, HG Park, JY Choi, K Song, ... Frontiers in Pharmacology 11, 608774, 2021 | 9 | 2021 |
| SMAD4 controls cancer cell metabolism by regulating methylmalonic aciduria cobalamin deficiency (cbl) B type K Song, HS Lee, L Jia, C Chelakkot, N Rajasekaran, YK Shin Molecules and cells 45 (6), 413-424, 2022 | 8 | 2022 |
| Macrosphelide A exhibits a specific anti-cancer effect by simultaneously inactivating ENO1, ALDOA, and FH K Song, N Rajasekaran, C Chelakkot, HS Lee, SM Paek, H Yang, L Jia, ... Pharmaceuticals 14 (10), 1060, 2021 | 7 | 2021 |
| Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches NA Kim, K Song, DG Lim, S Hada, YK Shin, S Shin, SH Jeong European Journal of Pharmaceutical Sciences 78, 177-189, 2015 | 7 | 2015 |
| Current development status of cytokines for cancer immunotherapy K Song Biomolecules & Therapeutics 32 (1), 13, 2024 | 6 | 2024 |
| Glycosylation heterogeneity of hyperglycosylated recombinant human interferon-β (rhIFN-β) K Song, DB Moon, NY Kim, YK Shin ACS omega 5 (12), 6619-6627, 2020 | 6 | 2020 |
| A glycoengineered interferon-β mutein (R27T) generates prolonged signaling by an altered receptor-binding kinetics S Lee, WS Son, HB Yang, N Rajasekaran, SS Kim, S Hong, JS Choi, ... Frontiers in Pharmacology 9, 1568, 2019 | 6 | 2019 |
